# $agen Agenus announces positive preclinical data for its novel immuno-oncology candidate, AGEN286, showing significant tumor regression in multiple cancer models. The company plans to initiate Phase [--] clinical trials in the second half of the year. ### About $agen Agenus is a biotechnology company focused on developing cancer immunotherapies. Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Agenus announces positive preclinical data for its novel immuno-oncology candidate, AGEN286, showing significant tumor regression in multiple cancer models. The company plans to initiate Phase [--] clinical trials in the second half of the year.
Agenus is a biotechnology company focused on developing cancer immunotherapies.
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$agen